The market is segmented based on , By Form (Injectable Solution, Nasal Spray, Tablet), Applications (Paediatric Use and Geriatric Use), End-Users (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy) – Industry Trends and Forecast to 2030.
.
The Global Desmopressin Market size was valued at USD 1055.63 USD Million in 2022.
The Global Desmopressin Market is projected to grow at a CAGR of 5.8% during the forecast period of 2023 to 2030.
The major players operating in the market include Pfizer Inc , Teva Pharmaceutical Industries Ltd , NorthStar Rx LLC , Sun Pharmaceutical Industries Ltd. , avenit software shanghai ltd , Ferring B.V. , Amring Pharmaceuticals Inc. , Apotex Inc , Glenmark Pharmaceuticals Ltd , Mylan N.V. .
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
Corporate Email ID Only (Avoid Using Generic mail ID such as Gmail)
Consent Preferences
We use cookies to improve your experience We use cookies to deliver the best possible experience on our website. To learn more, visit our Privacy Policy. By continuing to use this site, or closing this box, you consent to our use of cookies. Cookie Notice.
The data presented is for visualization purposes only and may not reflect actual results.